HomeCompareKGLLF vs MRK

KGLLF vs MRK: Dividend Comparison 2026

KGLLF yields 1460.92% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KGLLF wins by $552010657.42M in total portfolio value
10 years
KGLLF
KGLLF
● Live price
1460.92%
Share price
$0.14
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$552010657.48M
Annual income
$486,502,377,525,512.56
Full KGLLF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KGLLF vs MRK

📍 KGLLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKGLLFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KGLLF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KGLLF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KGLLF
Annual income on $10K today (after 15% tax)
$124,178.23/yr
After 10yr DRIP, annual income (after tax)
$413,527,020,896,685.70/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KGLLF beats the other by $413,527,020,888,357.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KGLLF + MRK for your $10,000?

KGLLF: 50%MRK: 50%
100% MRK50/50100% KGLLF
Portfolio after 10yr
$276005328.77M
Annual income
$243,251,188,767,655.34/yr
Blended yield
88.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KGLLF
No analyst data
Altman Z
54.7
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KGLLF buys
0
MRK buys
0
No recent congressional trades found for KGLLF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKGLLFMRK
Forward yield1460.92%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$552010657.48M$56.8K
Annual income after 10y$486,502,377,525,512.56$9,798.13
Total dividends collected$547228888.98M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KGLLF vs MRK ($10,000, DRIP)

YearKGLLF PortfolioKGLLF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$156,792$146,092.04$11,206$366.19+$145.6KKGLLF
2$2,308,522$2,140,754.05$12,650$502.35+$2.30MKGLLF
3$31,927,417$29,457,298.94$14,407$694.19+$31.91MKGLLF
4$414,911,536$380,749,199.40$16,585$967.82+$414.89MKGLLF
5$5,068,265,408$4,624,310,064.47$19,342$1,363.89+$5068.25MKGLLF
6$58,214,909,428$52,791,865,442.38$22,913$1,947.19+$58214.89MKGLLF
7$628,996,340,347$566,706,387,258.26$27,662$2,823.89+$628996.31MKGLLF
8$6,395,557,984,788$5,722,531,900,617.34$34,159$4,173.35+$6395557.95MKGLLF
9$61,222,691,542,196$54,379,444,498,472.16$43,337$6,308.80+$61222691.50MKGLLF
10$552,010,657,475,662$486,502,377,525,512.56$56,776$9,798.13+$552010657.42MKGLLF

KGLLF vs MRK: Complete Analysis 2026

KGLLFStock

KGL Resources Limited develops and explores for mineral properties. It explores copper, silver, gold, lead, and zinc deposits. The company engages in the exploration and development of the Jervois multi-metal project located in the Northern Territory, Australia. It also holds 100% interest in the Yambah project located in the northeast of Alice Springs; and the Unca Creek project located in the Bonya Metamorphics. The company was formerly known as Kentor Gold Limited and changed its name to KGL Resources Limited in August 2013. KGL Resources Limited was incorporated in 1998 and is based in Brisbane, Australia.

Full KGLLF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KGLLF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KGLLF vs SCHDKGLLF vs JEPIKGLLF vs OKGLLF vs KOKGLLF vs MAINKGLLF vs JNJKGLLF vs ABBVKGLLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.